RU2015146979A - Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена - Google Patents

Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена Download PDF

Info

Publication number
RU2015146979A
RU2015146979A RU2015146979A RU2015146979A RU2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A
Authority
RU
Russia
Prior art keywords
lactic acid
strain
acid bacteria
medicine according
rhamnosus cncm
Prior art date
Application number
RU2015146979A
Other languages
English (en)
Inventor
Эльза ЖАКУТОН
Эрве БЛОТТЬЕР
Тамара Смоквина
Жоэль ДОР
ХИЛКАМА ВЛИГ Йохан ВАН
Original Assignee
Компани Жервэ Данон
Энститю Насьональ Де Ля Решерш Агрономик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Компани Жервэ Данон, Энститю Насьональ Де Ля Решерш Агрономик filed Critical Компани Жервэ Данон
Publication of RU2015146979A publication Critical patent/RU2015146979A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)

Claims (6)

1. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства для предотвращения или лечения патологического состояния, являющегося результатом избыточного накопления жировой ткани и/или резистентности к инсулину.
2. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 1, отличающееся тем, что указанное патологическое состояние выбрано из избыточного веса, ожирения и болезней, являющихся их результатом.
3. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по любому из пп. 1 и 2, отличающееся тем, что указанный медикамент создан для перорального введения.
4. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 1 или 2, отличающееся тем, что указанный штамм содержится в композиции для перорального введения.
5. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 4, отличающееся тем, что указанная композиция представляет собой продукт питания или пищевую добавку.
6. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 4, отличающееся тем, что указанная композиция представляет собой молочный продукт.
RU2015146979A 2013-04-19 2014-04-18 Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена RU2015146979A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1353600A FR3004621B1 (fr) 2013-04-19 2013-04-19 Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique
FR1353600 2013-04-19
PCT/IB2014/060841 WO2014170879A1 (fr) 2013-04-19 2014-04-18 Souche de lactobacillus rhamnosus régulatrice du métabolisme lipidique

Publications (1)

Publication Number Publication Date
RU2015146979A true RU2015146979A (ru) 2017-05-24

Family

ID=49003844

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015146979A RU2015146979A (ru) 2013-04-19 2014-04-18 Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена

Country Status (6)

Country Link
US (1) US20160074444A1 (ru)
EP (1) EP3027061A1 (ru)
FR (1) FR3004621B1 (ru)
MX (1) MX2015014450A (ru)
RU (1) RU2015146979A (ru)
WO (1) WO2014170879A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113046276B (zh) * 2021-04-30 2022-03-18 澳优乳业(中国)有限公司 一种母乳源鼠李糖乳杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
KR100686557B1 (ko) * 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system

Also Published As

Publication number Publication date
FR3004621B1 (fr) 2015-05-15
WO2014170879A1 (fr) 2014-10-23
EP3027061A1 (fr) 2016-06-08
FR3004621A1 (fr) 2014-10-24
US20160074444A1 (en) 2016-03-17
MX2015014450A (es) 2016-05-05

Similar Documents

Publication Publication Date Title
PH12020500169A1 (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
RU2015129066A (ru) Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
BR112014008511A2 (pt) composições nutricionais com fitonutrientes
JP2015523321A5 (ru)
NZ601141A (en) Nutritional formulas containing synbiotics
IN2014KN02830A (ru)
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
MY191803A (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
RU2015122748A (ru) Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности
JP2017515499A5 (ru)
JP2015533509A5 (ru)
BRPI0811347A2 (pt) "extrato herbáceo medicinal dotado de efeito antiobesidade"
RU2015122728A (ru) Штамм lactobacillus rhamnosus для уменьшения накопления жира в организме
EP3612570A4 (en) POLYMER MATERIALS FOR DELIVERING SHORT CHAIN FATTY ACIDS TO THE INTESTINAL FOR HUMAN HEALTH APPLICATIONS AND DISEASE TREATMENT
WO2018093237A3 (ko) 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
RU2015146979A (ru) Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
BR112019008370A2 (pt) composição para tratamento preventivo ou curativo de distúrbios hepáticos
Zhou et al. OBSERVATION ON THE THERAPEUTIC EFFECT OF AURICULAR POINT STICKING ON SIMPLE OBESITY
Hsieh et al. Novel Concepts to Develop an" All-in-One" Functional Food for Health and Disease Prevention in the 21~(st) Century by Biomarkers Technology

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20180418